The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up results of ipilimumab and nivolumab for the treatment of mismatch repair deficient locally advanced rectal cancer.
 
Danny Trotier
No Relationships to Disclose
 
Nataliya Volodymyrivna Uboha
Stock and Other Ownership Interests - Exact Sciences (I); Natera (I)
Consulting or Advisory Role - Aptitude Health; Astellas Pharma; Astellas Pharma; AstraZeneca; BostonGene; Bristol Myers Squibb Foundation; Bristol-Myers Squibb/Roche; Eisai/MSD; Elevation Oncology; GRAIL; Helsinn Therapeutics; Ipsen; ipsen; Pfizer
Research Funding - EMD Serono (Inst); ipsen (Inst)
 
Kristina A. Matkowskyj
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Jeremy D. Kratz
Research Funding - BMS; Boehringer Ingelheim
 
Evie Carchman
No Relationships to Disclose
 
Eilse Lawson
No Relationships to Disclose
 
Cristina Sanger
No Relationships to Disclose
 
Charles Heise
No Relationships to Disclose
 
Sam Joseph Lubner
Stock and Other Ownership Interests - Elephas Bio
Consulting or Advisory Role - Elephas Bio
Research Funding - Agios (Inst); AstraZeneca/MedImmune/Spirogen (Inst); Bristol Myers Squibb Foundation (Inst); Incyte (Inst)
 
Monica Arun Patel
Honoraria - OncLive/MJH Life Sciences
 
Noelle K. LoConte
Consulting or Advisory Role - Abbvie; Abbvie; Personal Genome Diagnostics
Research Funding - Exact Sciences
 
Michael F. Bassetti
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Bayer; Lilly; Pfizer; Seagen
Research Funding - AADi (Inst); Arcus Ventures (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Curegenix (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Natera (Inst); Promega (Inst); Revolution Medicines (Inst); Strata Oncology (Inst)